Healthy men test new oral edaravone combo for safety
NCT ID NCT04481789
First seen Jun 26, 2026 · Last updated Jul 16, 2026 · Updated 3 times
Summary
This completed Phase 1 study looked at how an oral form of edaravone interacts with three other drugs (rosuvastatin, sildenafil, and furosemide) in healthy adult men. It also compared how Japanese and Caucasian men process edaravone. The goal was to gather safety and drug-level data, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Edaravone (oral suspension)
- What this could lead to
- If successful, this study could help doctors understand how to safely combine oral edaravone with other common medications.
- What could go wrong
- This is an early-stage study in healthy volunteers, not patients. Results may not apply to people with illnesses, and drug interactions could still cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Investigational site
Tokyo, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill help regulate blood sugar? early trial puts PSTC100 to the test
- First human trial launches for experimental PSTB100 drug
- Syringe showdown: does a prefilled device deliver drug as well as a vial?
- Healthy volunteers help unlock the Body's handling of a new drug
- New edaravone tablet tested in healthy volunteers
- Healthy volunteers test new Drug's body processing